Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1631 1641 1677 1678
This examiner grants 32% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17919052 | ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 17907510 | GENOME ENGINEERING USING CRISPR RNA-GUIDED INTEGRASES | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 16487517 | METHODS OF PHOTOCHEMICAL TREATMENT FOR WOUND HEALING | Non-Final OA | The General Hospital Corporation |
| 18317772 | METHODS OF TREATING METACHROMATIC LEUKODYSTROPHY | Non-Final OA | Genzyme Corporation |
| 17870607 | RIBOSOME TERMINATION STRUCTURES AND USE THEREOF | Non-Final OA | RAMOT AT TEL-AVIV UNIVERSITY LTD |
| 18298882 | COMBINATION TREATMENT | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18001462 | 3D CULTURE OF MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS | Final Rejection | MESOBLAST INTERNATIONAL SÁRL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy